In vitro T-cell receptor stimulation of splenocytes revealed a significant systemic inhibition of tumour necrosis factor (TNF)-α production in both AIP-1- and AIP-1Q119-treated mice, which correlates with the suppression of TNBS-induced pathology observed previously (Figure 4a). The gene discussed is TNF; the disease is autoimmune pancreatitis.